You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窝轮》【瑞通认股证牛熊证】恒指考验10天线、资金捞牛 美团弹穿270元、投资者一面倒开熊 恒指牛62793 熊57927/ 美团牛证51458 熊59361/ 比迪牛53758 进取熊55040
阿思达克 05-20 10:57
联储局会议纪录显示,部分委员开始考虑缩减买债规模。道指隔晚一度挫逾580点,收市跌幅收窄至164点(或0.5%),报33896点。

恒指假期前收报28593点,升399点(或1.4%),连升三日并重上10天和20天线。今早一度回吐300点,至28300点以下,暂於10天线见支持。恒指好仓(牛证及认购权证)周二净流出逾8200万港元(下同),恒指淡仓(熊证及认沽权证)同日净流入逾1.4亿元,反映投资者预期港股将见调整。周二恒指牛证街货重货区为收回价27000至27099点,而熊证街货重货区为收回价29000至29099点。

美团(03690)在假期前夕录约9.4亿元北水净买入,是净流入第二多港股,股份收升2.3%,企260元。美团将於下周五公布今年首季度业绩,券商料公司在社区团购等新业务上加大投入,上季亏损会进一步扩大,并聚焦其社区团购及监管指引。美团今早先跌後回升近半成,重上10天线(约263.2元)及270元关口,暂连升三日。分别有约860万元和逾2400万元在周二净流出其轮证好仓和淡仓。

比亚迪股份(01211)昨完成生产第100万辆新能源汽车,并宣布比亚迪乘用车将进军欧洲,首站选址挪威。另外,工信部、生态环境部、海关总署三部门近日联合发公告,7月起全国全面实施重型柴油车国六排放标准,禁止生产、销售不符标准的重型柴油车。比亚迪在假期前逆市收跌1%於151.3元,盘中低见148.4元,险守10天线,两连升结束。今早回升逾7%,迫近163元见阻力。周二有逾520万元净流入其好仓,淡仓同日则有逾140万元净流出。

小米(01810)周二以全日高位26.6元收市,涨1.7%,连升三日。集团将於下周三公布首季业绩,券商料期内非国际财务报告准则经调整净利润介乎33亿至逾45亿元人民币,按年升46.4%至98.5%。印度市场情况及集团拓展电动车指引等将是市场关注焦点。小米今早低开後回稳,曾升穿27元水平。逾900万元在周二净流出其好仓,淡仓同日则有逾140万元净流入。

药明生物(02269)周二同样以全日高位收市,报109.9元,升1.9%,三连升并企稳各移动平均线之上,亦重越上月107元配股价。股份今早好淡争持,曾重上110元後回落。周二分别有逾150万元和逾10万元净流入其好仓和淡仓。

瑞通相关认股证之选择:

美团轻微价外、短期购21193,行使价:302.08元,2021年7月到期,实际杠杆:8.4倍

美团轻微价外、中年期沽26159,行使价:230元,2021年12月到期,实际杠杆:3.7倍

比迪轻微价外、中年期购24154,行使价:176.88元,2021年12月到期,实际杠杆:4倍

比迪价外、中年期沽11047,行使价:121元,2021年11月到期,实际杠杆:3.8倍

小米轻微价外、中短期购27574,行使价:28.93元,2021年8月到期,实际杠杆:6.7倍

小米轻微价外、中短期沽17277,行使价:23.88元,2021年8月到期,实际杠杆:6.9倍

药明轻微价外、中短期购26864,行使价:126.88元,2021年8月到期,实际杠杆:5.6倍

新保轻微价外、中年期购20719,行使价:31.88元,2021年12月到期,实际杠杆:4.9倍

网易贴价、中短期购18309,行使价:178.88元,2021年10月到期,实际杠杆:5.6倍

瑞通相关牛熊证之选择:

恒指牛证62793,收回价:27760点,杠杆比率:34倍

恒指熊证57927,收回价:28940点,杠杆比率:38倍

恒科牛证58783,收回价:7000元,杠杆比率:7.2倍

恒科熊证60082,收回价:8500元,杠杆比率:9.6倍

美团牛证51458,收回价:237.99元,杠杆比率:7.3倍

美团熊证59361,收回价:292.88元,杠杆比率:9.3倍

比迪牛证53758,收回价:135.38元,杠杆比率:4.6倍

比迪进取熊证55040,收回价:168.88元,杠杆比率:9.4倍

比迪中远距离熊证53954,收回价:188.88元,杠杆比率:5倍

小米牛证62126,收回价:24.51元,杠杆比率:8.7倍

小米熊证56688,收回价:29.38元,杠杆比率:8.4倍

药明牛证62773,收回价:95.88元,杠杆比率:6.5倍

药明熊证56714,收回价:118.8元,杠杆比率:8.1倍

网易牛证60132,收回价:152元,杠杆比率:6.8倍

网易熊证53623,收回价:214元,杠杆比率:3.8倍

重要风险通知

本结构性产品并无抵押品。

结构性产品之价格一般可急升亦可急跌,有可能损失结构性产品之全部或重大部分购买价,阁下对此应有所准备。

阁下投资前应了解产品风险,如有需要应谘询专业建议。~

重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account